Clin2
NCT06647602Possibly a fitNot yet recruiting

Thyroid hormone after radioactive iodine treatment

Differentiated Thyroid CancerThyroid CancerLevothyroxineLiothyronineThyroid Hormones

Part of Cancer, Hormones & metabolism clinical trials.

This study compares two ways of replacing thyroid hormone after radioactive iodine therapy for high-risk thyroid cancer. It aims to find which approach is more effective and better for patients.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
18 years to 75 years
Study type
Observational

Who can take part

  • You have a type of thyroid cancer called differentiated thyroid cancer (papillary, follicular, or oncocytic).
  • Your cancer is considered high-risk or likely to come back, as judged by your doctor.
  • You are preparing for radioactive iodine therapy by stopping your thyroid hormone medication.
  • You are able to follow the study plan and understand Dutch.
  • You are not pregnant and do not have severe heart problems or other conditions that would make the study treatment unsafe.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05599139Recruiting
Testing iodine uptake after a low-iodine diet

This study looks at how much iodine your body absorbs after you follow a low-iodine diet before radioactive iodine treatment (131I) for thyroid cancer. It may help improve how safely and effectively this treatment is planned.

Groningen, Provincie Groningen
NCT07453225Not yet recruiting· Phase 1/Phase 2
Radioactive iodine treatment for persistent thyroid cancer

This trial tests if a standard radioactive iodine treatment can help people with a type of thyroid cancer (called differentiated thyroid cancer) who have signs of the disease returning after their first treatment. It aims to see if this treatment can control the cancer and improve outcomes.

NCT06087068Recruiting· Phase 2
Thyroid hormone therapy after lobectomy for low-risk thyroid cancer

This trial is testing whether thyroid hormone replacement after surgery is safe for people with low-risk papillary thyroid cancer. It may help maintain normal hormone levels after part of the thyroid is removed.

Beijing, Beijing Municipality
NCT07056218Not yet recruiting
Radioactive iodine therapy for low and intermediate risk thyroid cancer

This trial studies how well radioactive iodine treatment works for people with certain types of thyroid cancer that have a low or intermediate risk of coming back. It aims to see if this treatment is effective and safe for these patients.

NCT06558981Recruiting· Phase 3
Radiation therapy after thyroid surgery for high-risk cancer

This trial is testing whether giving radiation therapy after thyroid surgery can help destroy any leftover cancer cells in people with high-risk differentiated thyroid cancer. It is for those who had surgery but some cancer was still left behind.

Shanghai
NCT06134830Not yet recruiting
Radioactive iodine doses for thyroid cancer

This study looks at how different doses of radioactive iodine affect people with thyroid cancer after they have had their thyroid removed. It may help doctors choose the best dose for future patients.

Hear when a new Differentiated Thyroid Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.